We provide you with 20 years of free, institutional-grade data for RVNC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RVNC. Explore the full financial landscape of RVNC stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Foley Mark J | Sale | -20,533 | $5.3 | $108,928 | 2024-03-19 |
| Schilke Tobin | Sale | -13,183 | $5.3 | $69,936 | 2024-03-19 |
| Sjuts Dustin S | Sale | -12,178 | $5.3 | $64,604 | 2024-03-19 |
| Moxie Dwight | Sale | -11,394 | $5.3 | $60,445 | 2024-03-19 |
| Foley Mark J | Open Market Purchase | 30,000 | $6.98 | 2024-03-08 | |
| Sjuts Dustin S | Grant, award...etc | 22,110 | 2024-03-04 | ||
| Moxie Dwight | Grant, award...etc | 15,143 | 2024-03-04 | ||
| Foley Mark J | Grant, award...etc | 70,750 | 2024-03-04 | ||
| Schilke Tobin | Grant, award...etc | 17,447 | 2024-03-04 | ||
| Jordan Erica | Initial | 2024-02-29 | |||
| Hollander David | Initial | 2024-02-29 | |||
| Moxie Dwight | Grant, award...etc | 90,000 | 2024-02-02 | ||
| Schilke Tobin | Grant, award...etc | 96,667 | 2024-02-02 | ||
| Sjuts Dustin S | Grant, award...etc | 264 | $7.47 | 2024-01-03 | |
| Schilke Tobin | Grant, award...etc | 434 | $7.47 | 2024-01-03 | |
| Foley Mark J | Grant, award...etc | 264 | $7.47 | 2024-01-03 | |
| Sjuts Dustin S | Sale | -4,712 | $8.08 | $38,073 | 2023-12-18 |
| Moxie Dwight | Sale | -34,853 | $17.81 | $620,875 | 2023-09-07 |
| Schilke Tobin | Sale | -11,215 | $18.91 | $212,076 | 2023-08-15 |
| Schilke Tobin | Grant, award...etc | 22,620 | 2023-08-15 | ||
| Moxie Dwight | Sale | -9,592 | $18.91 | $181,385 | 2023-08-15 |
| Moxie Dwight | Grant, award...etc | 19,346 | 2023-08-15 | ||
| Sjuts Dustin S | Sale | -8,901 | $18.91 | $168,318 | 2023-08-15 |
| Sjuts Dustin S | Grant, award...etc | 22,620 | 2023-08-15 | ||
| Foley Mark J | Sale | -48,064 | $18.91 | $908,890 | 2023-08-15 |
| Foley Mark J | Grant, award...etc | 122,143 | 2023-08-15 | ||
| Foley Mark J | Sale | -26,279 | $22.57 | $593,151 | 2023-08-04 |
| Schilke Tobin | Sale | -1,701 | $25.04 | $42,593 | 2023-07-05 |
| Schilke Tobin | Grant, award...etc | 769 | $15.61 | 2023-07-05 | |
| Sjuts Dustin S | Grant, award...etc | 1,000 | $15.61 | 2023-07-05 | |
| Foley Mark J | Sale | -26,279 | $24.94 | $655,333 | 2023-07-05 |
| Foley Mark J | Grant, award...etc | 1,000 | $15.61 | 2023-07-05 | |
| Kolaja Carey OConnor | Sale | -2,500 | $28.24 | $70,600 | 2023-06-20 |
| Kolaja Carey OConnor | Derivatives Exercise | 2,500 | 2023-06-20 | ||
| Sjuts Dustin S | Sale | -5,000 | $30.82 | $154,096 | 2023-06-13 |
| Foley Mark J | Sale | -31,279 | $30.72 | $960,928 | 2023-06-13 |
| Schilke Tobin | Sale | -3,201 | $30.57 | $97,855 | 2023-06-05 |
| Foley Mark J | Sale | -70,447 | $34.55 | $2,433,725 | 2023-05-16 |
| Foley Mark J | Grant, award...etc | 175,649 | 2023-05-16 | ||
| Sjuts Dustin S | Sale | -21,015 | $34.55 | $726,003 | 2023-05-16 |
| Sjuts Dustin S | Grant, award...etc | 52,395 | 2023-05-16 | ||
| Schilke Tobin | Sale | -21,401 | $34.55 | $739,338 | 2023-05-16 |
| Schilke Tobin | Grant, award...etc | 42,349 | 2023-05-16 | ||
| Moxie Dwight | Sale | -21,401 | $34.55 | $739,338 | 2023-05-16 |
| Moxie Dwight | Grant, award...etc | 42,349 | 2023-05-16 | ||
| Gangolli Julian S | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Ware Olivia C | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Nolet Chris | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Kolaja Carey OConnor | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Russell Angus C. | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Coric Vlad | Grant, award...etc | 589 | 2023-05-05 | ||
| Beraud Jill | Grant, award...etc | 3,534 | 2023-05-05 | ||
| Schilke Tobin | Sale | -3,201 | $31.7 | $101,472 | 2023-05-02 |
| Schilke Tobin | Sale | -3,201 | $32.15 | $102,912 | 2023-04-04 |
| Foley Mark J | Sale | -5,341 | $30.65 | $163,702 | 2023-03-17 |
| Schilke Tobin | Sale | -3,739 | $30.65 | $114,600 | 2023-03-17 |
| Moxie Dwight | Sale | -7,330 | $30.65 | $224,665 | 2023-03-17 |
| Sjuts Dustin S | Sale | -2,967 | $30.65 | $90,939 | 2023-03-17 |
| Moxie Dwight | Sale | -18,496 | $31.59 | $584,220 | 2023-03-09 |
| Moxie Dwight | Grant, award...etc | 42,349 | 2023-03-09 | ||
| Schilke Tobin | Sale | -18,517 | $31.59 | $584,884 | 2023-03-09 |
| Schilke Tobin | Grant, award...etc | 42,349 | 2023-03-09 | ||
| Sjuts Dustin S | Sale | -21,508 | $31.59 | $679,358 | 2023-03-09 |
| Sjuts Dustin S | Grant, award...etc | 52,396 | 2023-03-09 | ||
| Foley Mark J | Sale | -70,390 | $31.59 | $2,223,360 | 2023-03-09 |
| Foley Mark J | Grant, award...etc | 175,649 | 2023-03-09 | ||
| Coric Vlad | Grant, award...etc | 5,195 | 2023-03-03 | ||
| Schilke Tobin | Sale | -3,201 | $33.5 | $107,234 | 2023-03-02 |
| Schilke Tobin | Sale | -2,085 | $33.21 | $69,243 | 2023-02-16 |
| Sjuts Dustin S | Sale | -2,766 | $33.21 | $91,859 | 2023-02-16 |
| Schilke Tobin | Sale | -3,201 | $34.6 | $110,755 | 2023-02-02 |
| Schilke Tobin | Sale | -1,000 | $31 | $31,000 | 2023-01-23 |
| Schilke Tobin | Sale | -3,701 | $25 | $92,525 | 2023-01-10 |
| Foley Mark J | Grant, award...etc | 605 | $12.18 | 2023-01-03 | |
| Sjuts Dustin S | Grant, award...etc | 605 | $12.18 | 2023-01-03 | |
| Schilke Tobin | Grant, award...etc | 645 | $12.18 | 2023-01-03 | |
| Schilke Tobin | Sale | -1,557 | $21.5 | $33,476 | 2022-12-16 |
| Sjuts Dustin S | Sale | -2,916 | $21.5 | $62,694 | 2022-12-16 |
| Foley Mark J | Sale | -49,274 | $26.97 | $1,328,920 | 2022-10-14 |
| Moxie Dwight | Sale | -11,000 | $27.07 | $297,798 | 2022-09-16 |
| Schilke Tobin | Grant, award...etc | 965 | $11.75 | 2022-07-05 | |
| Foley Mark J | Grant, award...etc | 1,000 | $11.75 | 2022-07-05 | |
| Sjuts Dustin S | Grant, award...etc | 1,000 | $11.75 | 2022-07-05 | |
| Vickers Philip J. | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Nolet Chris | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Gangolli Julian S | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Kolaja Carey OConnor | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Beraud Jill | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Russell Angus C. | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Ware Olivia C | Grant, award...etc | 6,059 | 2022-05-06 | ||
| Joshi Abhay | Sale | -2,607 | $15.79 | $41,165 | 2022-03-17 |
| Rankin Aubrey | Sale | -1,372 | $15.79 | $21,664 | 2022-03-17 |
| Foley Mark J | Sale | -3,304 | $15.79 | $52,170 | 2022-03-17 |
| Moxie Dwight | Sale | -5,110 | $15.79 | $80,687 | 2022-03-17 |
| Schilke Tobin | Sale | -2,607 | $15.79 | $41,165 | 2022-03-17 |
| Sjuts Dustin S | Sale | -1,835 | $15.79 | $28,975 | 2022-03-17 |
| Sjuts Dustin S | Sale | -2,429 | $13.35 | $32,427 | 2022-02-17 |
| Joshi Abhay | Sale | -5,053 | $13.35 | $67,458 | 2022-02-17 |
| Schilke Tobin | Sale | -2,924 | $13.35 | $39,035 | 2022-02-17 |
The information provided in this report about RVNC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Revance Therapeutics, Inc(NASDAQ:RVNC) 
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (D...
Website: http://www.revance.com
Founded: 1999
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology